月旦知識庫
  1. 熱門:
 
首頁 臺灣期刊   法律   公行政治   醫學   財經   社會學   教育   其他 大陸期刊   核心   非核心 DOI文章
查看詳細全文
篇名
古今中醫對肝纖維化治療觀點之探討
並列篇名
AN ANALYSIS OF ANTIQUE TO CURRENT CHINESE MEDICAL ANTI-LIVER FIBROSIS CONCEPTS
作者 林宏任鄭如茜高尚德
中文摘要
根據衛生署九十八年統計十大死亡原因,慢性肝病與肝硬化高居我國十大死因之第七位,每年大約有五千人死亡,可謂之為國病,也因此付出巨大的社會成本。無論中西醫學者針對慢性肝病患者進一步轉變成肝纖維化或肝硬化,在臨床或實驗室研究中,莫不思考相關因應對策,以求其突破瓶頸。本文藉以古籍論述、近代古今中醫學及現階段中醫藥研究針對肝纖維化之看法做一比較,探討未來中醫在臨床上對肝纖維化的治療策略。According to statistical information gathered by the Department of Health, chronic liver disease and liver cirrhosis are currently ranked at number 7 out of the top 10 leading causes of death in 2009. In the ROC, on average 5,000 citizens die each year from liver disease, making it a national epidemic. Regardless of race or location, some patients who have chronic liver disease will eventually get liver fibrosis or liver cirrhosis. Both Chinese or Western physicians are actively studying clinical and laboratory research and trying hard to find a breakthrough, which has yet to be found that can offer a solution to face this growing problem. This article is comparing and discussing the Chinese theory of liver fibrosis from antiquity to the previous century, as well as focusing on Chinese medicine’s research in the current day. It is also an analysis of the strategy of Chinese medicine dealing with anti-liver fibrosis concepts to find a cure in the future.
起訖頁 99-110
關鍵詞 子宮頸閉鎖不全先兆早產安胎中西醫結合治療Cervical incompetenceThreatened preterm laborTocolysisCombination of Chinese medicine and modern medicine
刊名 中醫藥雜誌  
期數 201012 (21:3-4期)
出版單位 衛生福利部國家中醫藥研究所(原:國立中國醫藥研究所)
該期刊-上一篇 穿心蓮乙素 (andrographolide) 經由抑制iNOS和gp91phox/NADPH oxidase 2 (NOX2) 的表現保護缺血型中風大鼠腦組織
該期刊-下一篇 從《傷寒論》論緊脈脈形之特色及與弦脈脈形之鑑別
 

新書閱讀



最新講座


優惠活動




讀者服務專線:+886-2-23756688 傳真:+886-2-23318496
地址:臺北市館前路28 號 7 樓 客服信箱
Copyright © 元照出版 All rights reserved. 版權所有,禁止轉貼節錄